Drug-labels.com

Apo-Nabilone: Uses, Side Effects and Dosage

Updated:
Facts
Status:
Prescription (Rx) NARCOTICS (CDSA II)
Strength:
0.25 mg, 0.5 mg, 1 mg
Active ingredient:
ATC code:

Patient Medication Information: uses, side effects, how to take - Apo-Nabilone

ABOUT THIS MEDICATION

What the medication is used for:

APO-NABILONE (nabilone) is indicated for the management of severe nausea and vomiting associated with cancer therapy.

What it does:

APO-NABILONE decreases nausea (sensation of feeling sick) and vomiting.

When it should not be used:

You should not take APO-NABILONE if:

  • you have known sensitivity to marijuana or other cannabinoid agents
  • you have a history of psychotic reactions
  • you are under the age of 18 years
  • you are breastfeeding

  • you are pregnant

What the medicinal ingredient is:

The medicinal ingredient in APO-NABILONE is nabilone, a synthetic cannabinoid agent.

What the non-medicinal ingredients are:

APO-NABILONE contains the following non-medicinal ingredients: D&C red No. 33 (0.5 mg capsule), D&C yellow No. 10 (0.25 and 0.5 mg capsules), FD&C blue No. 1 (0.25 mg capsule), FD&C blue No. 2 (1 mg capsule), FD&C red No. 40 (0.25 and 0.5 mg capsules), gelatin, iron oxide red (1 mg capsule), povidone, pregelatinized starch, talc and titanium dioxide. The capsule shells are imprinted with black edible ink and contain ammonium hydroxide, iron oxide black, propylene glycol and shellac.

What dosage forms it comes in:

APO-NABILONE (nabilone) is formulated into capsules of 0.25 mg, 0.5 mg, or 1 mg strengths for oral administration.

WARNINGS AND PRECAUTIONS

Serious Warnings and Precautions

  • Since APO-NABILONE will often impair the mental and/or physical abilities required for the performance of potentially hazardous task, you should not drive a car, operate machinery, or perform any activity that requires mental alertness until the effects of APO-NABILONE are no longer present.
  • While taking APO-NABILONE, do not drink alcohol or take other drugs such as sedatives, hypnotics or other substances that can affect the nervous system without consulting with your doctor.
  • APO-NABILONE should be used with extreme caution if you have severe liver dysfunction or a history of non-psychotic emotional disorders.

BEFORE you use APO-NABILONE talk to your doctor or pharmacist if:

  • you are taking any other prescription or non-prescription medicine, or natural/herbal remedies
  • you are pregnant or breastfeeding
  • you are allergic to nabilone, the main ingredient in APO-NABILONE, or any other ingredient in APO-NABILONE (see “What the non-medicinal ingredients are”)
  • you have hypertension or heart problems

INTERACTIONS WITH THIS MEDICATION

While you are taking APO-NABILONE, do not start any new medicines, including natural or herbal medicines, without speaking to your doctor first. Tell your doctor about all the medicines that you are taking including those that you have bought yourself.

APO-NABILONE can interact with:

  • Diazepam
  • Sodium secobarbital
  • Alcohol

  • Codeine
  • Any medicine that affects your mental and psychomotor function (e.g., causes hallucinations, weird thoughts, etc).

PROPER USE OF THIS MEDICATION

The label on the container of your medicine should tell you how often to take your medicine and how many doses you should take each time. If not, or if you are not sure, ask your doctor or pharmacist.

Do not take more doses, or take them more often than your doctor prescribes.

Your doctor prescribed APO-NABILONE for your use only. You should not let anyone else use it.

Usual Adult Dose:

You will receive APO-NABILONE prior to chemotherapy and, if necessary, after cancer treatment. Based on how likely you are to experience nausea and/or vomiting, caused by your cancer treatment, your doctor will tell you the amount you need to take and how frequently. Follow the directions provided by your doctor for using this medicine. Your doctor may also have to adjust your dose depending on how you react to APO-NABILONE.

Overdose:

If you think you have taken too much APO-NABILONE, contact your healthcare professional, hospital emergency department or regional Poison Control Centre immediately, even if there are no symptoms.

Some of the signs of overdose are psychotic episodes including hallucinations, anxiety reactions, respiratory depression, and coma.

Overdose may even occur at prescribed doses. If psychiatric symptoms (e.g., weird thoughts, hallucinations, etc.) are present, contact poison control centre immediately or go to the nearest emergency room.

Missed Dose:

If you forget a dose of APO-NABILONE, you should take it as soon as you remember. However, if it is almost time for the next dose, skip the missed dose and go back to the regular dosing schedule. Do not double your dose.

SIDE EFFECTS AND WHAT TO DO ABOUT THEM

Some patients may experience drowsiness, psychological high, vertigo, dry mouth, depression, ataxia, asthenia, blurred vision, sensation disturbance, anorexia, headache, orthostatic hypotension, euphoria, and hallucinations. You should tell your doctor or pharmacist about these symptoms.

If your nausea (feeling of sickness) or vomiting do not improve while taking APO-NABILONE, consult your doctor for further advice.

If you feel unwell or have any symptoms that you do not understand, you should contact your doctor immediately.

SERIOUS SIDE EFFECTS, HOW OFTEN THEY HAPPEN AND WHAT TO DO ABOUT THEM
Symptom / effectTalk with your doctor or pharmacistStop taking drug and seek immediate emergency medical attention
Only if severeIn all cases
CommonDrowsiness√
Dry mouth√
Euphoria√
Hallucinations√
Somnolence√
Vertigo√
UncommonConfusion√
Depression√
Dissociation√
Headache√
Orthostatic hypotension√
Nightmares√
Seizure√
Tachycardia√
Tremors√

This is not a complete list of side effects. For any unexpected effects while taking APO-NABILONE, contact your doctor or pharmacist immediately.

HOW TO STORE IT

Keep APO-NABILONE out of sight and reach of children.

Store at controlled room temperature 15°C-30°C in a tightly closed container.

Reporting Side Effects

You can help improve the safe use of health products for Canadians by reporting serious and unexpected side effects to Health Canada. Your report may help to identify new side effects and change the product safety information.

3 ways to report:

  • Online at MedEffect;
  • By calling 1-866-234-2345 (toll-free);
  • By completing a Consumer Side Effect Reporting Form and sending it by:

    • Fax to 1-866-678-6789 (toll-free), or
    • Mail to: Canada Vigilance Program

      Health Canada, Postal Locator 0701E

      Ottawa, ON

      K1A 0K9

      Postage paid labels and the Consumer Side Effect Reporting Form are available at MedEffect.

NOTE: Contact your health professional if you need information about how to manage your side effects. The Canada Vigilance Program does not provide medical advice.

MORE INFORMATION

For more information, please contact your doctor, pharmacist or other healthcare professional.

This leaflet plus the full product monograph, prepared for health professionals, can be obtained by contacting DISpedia, Apotex’s Drug Information Service at:

1-800-667-4708

Last prepared: May 15, 2015

About this document

Source: Health Canada – Drug Product Database (DPD) and product monographs · DIN (Drug Identification Number): 02441497

Revision date stated in the text: May 15, 2015

Found a mistake? Write to us via the contact page.

The information on this site does not replace the advice of a doctor or pharmacist.

Drug information for Apo-Nabilone

Rx or OTC
Prescription (Rx)?
DIN 02441497, 02441500, 02441519
Schedule(s) NARCOTICS (CDSA II)
Active ingredient(s) Nabilone
Dosage form(s) Capsule
Route(s) of administration Oral
Drug class (WHO ATC)
  1. A Alimentary tract and metabolism drugs
    1. A04 Antiemetics and antinauseants
      1. A04A Antiemetics and antinauseants
        1. A04AD Other antiemetics
          1. A04AD11 Nabilone
Company APOTEX INC
Current status Approved
Current status date May 20, 2015
Strengths and forms
DIN Strength Dosage form(s) Current status
02441497 0.25 MG Capsule Approved May 20, 2015
02441500 0.5 MG Capsule Approved May 20, 2015
02441519 1 MG Capsule Approved May 20, 2015

Source: Health Canada – Drug Product Database (DPD) and product monographs, data as of November 1, 2026. Data from the Health Canada Drug Product Database, as published there. Not a substitute for the advice of a doctor or pharmacist.